Carevive’s Longitudinal Data

At Carevive, our commitment to enhancing cancer care through data-driven insights is at the core of our mission. Our real-time, longitudinal data set offers comprehensive and up-to-date information on patient experiences throughout their cancer journey.

With over 1,700 patients represented across 26 cancer types, our registry provides a wealth of information from more than 19,000 completed surveys conducted over two years. This rich dataset encompasses over 600,000 unique data points, providing valuable information for analysis and personalized care planning.

One of the key strengths of our approach is seamless integration with the care process. Our surveys are presented to patients by their care teams, ensuring an outstanding survey response rate of 82% or higher for some indications. This compliance underscores the importance of patient engagement in the treatment process.

Carevive’s real-time data empowers care teams with valuable insights, enabling them to make informed decisions, proactively address patient concerns, and optimize treatment plans. Our commitment to advancing cancer care through data excellence sets the stage for continued innovation and improved patient outcomes.

Recent Episodes

As eye care rapidly evolves, Vision Expo East 2025 is the place to see where innovation meets clinical excellence — and Reichert is leading the charge. At booth F2201, practitioners can experience hands-on demos of Reichert’s latest breakthroughs in tonometry, digital refraction, and dry eye diagnostics. Of particular note is the new Tono-Vera® Tonometer,…

In the latest episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims, Chief Marketing & Communications Officer at TruMerit (formerly CGFNS International, Inc.), is joined by Jim Campbell, Director of Health Workforce at the World Health Organization (WHO), and Peter Preziosi, President & CEO of TruMerit. Together, they explore pressing global…

In this episode of Exceeding Your Benchmark, host Michelle Dawn Mooney speaks with Abby Roth, founder of Pure Microbiology, about sterile compounding and contamination control. Abby shares her expertise in microbiology, sterile environments, and best practices in pharmaceutical compounding. The conversation begins with a distinction between traditional drug manufacturing and sterile compounding, highlighting the…